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OBJECTIVES We tested the hypothesis that coronary flow reserve (CFR) in the left anterior descending
coronary artery (LAD) as assessed by a new noninvasive method (contrast-enhanced
transthoracic second harmonic echo Doppler) is in agreement with CFR measurements
assessed by intracoronary Doppler flow wire.
BACKGROUND Contrast-enhanced transthoracic second harmonic echo Doppler is a novel noninvasive
method to detect blood flow velocity and reserve in the LAD. However, it has not yet been
validated versus a gold-standard method.
METHODS Twenty-five patients undergoing CFR assessment in the LAD by Doppler flow wire were
also evaluated by contrast-enhanced transthoracic Doppler to record blood flow in the distal
LAD at rest and during hyperemia obtained by adenosine IV infusion. In five patients CFR
was evaluated twice (before and after angioplasty).
RESULTS As a result of the combined use of IV contrast and second harmonic Doppler technology,
feasibility in assessing coronary flow reserve equaled 100%. The agreement between the two
methods was high. In fact, in all but five patients the maximum difference between the two
CFR measurements was 0.38. Overall, the prediction (95%) interval of individual differences
was 20.69 to 10.72. Reproducibility of CFR measurements was also high. The limits of the
agreement (95%) between the two measurements were 20.32 to 10.32.
CONCLUSIONS Coronary flow reserve in the LAD as assessed by contrast-enhanced transthoracic echo
Doppler along with harmonic mode concurs very closely with Doppler flow wire CFR
measurements. This new noninvasive method allows feasible, reliable and reproducible
assessment of CFR in the LAD. (J Am Coll Cardiol 1999;34:1193–200) © 1999 by the
American College of Cardiology
Coronary flow reserve (CFR) is an important functional
parameter to understand the pathophysiology of coronary
circulation. However, a large-scale assessment of this im-
portant functional parameter is hampered by the lack of a
reliable, low-cost, noninvasive method. In fact, the available
methodologies in assessing CFR are either invasive (intra-
coronary Doppler flow wire [IDFW]) (1) or expensive and
scarcely available (positron emission tomography) (2). Some
years ago transesophageal echocardiography (TEE) was
proposed for assessing CFR in humans (3). However, this
method bears some important limitations: it is semi-
invasive, it has suboptimal feasibility in visualizing flow in
the left anterior descending coronary artery (LAD) (ranging
from 69% to 89%) and it can allow only the assessment of
prestenotic CFR in coronary artery disease (CAD) patients.
Distal LAD, having a superficial course close to the
anterior chest wall, can be visualized by transthoracic
echocardiography (TTE). Several studies have in fact dem-
onstrated the potential of TTE for this purpose. Unfortu-
nately, in these studies the feasibility in visualizing flow in
distal LAD was low, hampering clinical applicability of the
method for CFR.
Doppler signal from coronaries can be enhanced by using
intravenously injected contrast agents that survive transpul-
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monary passage. Harmonic Doppler can further enhance
Doppler signal-to-noise ratio by reducing the noise coming
from the tissue without reducing Doppler signal intensity
(4,5). We have recently demonstrated that blood flow
velocity Doppler recording during a transthoracic study can
be greatly improved using contrast and second harmonic
Doppler technology; CFR as assessed by this new method
can very well predict significant stenosis affecting the LAD,
and in a small, preliminary series of patients, using dipyr-
idamole as vasodilator, it agrees with an independent
reference method such as IDFW (6).
However, this new promising method has yet to be
validated versus a gold-standard method such as IDFW in
a larger series of patients using adenosine as hyperemic
stimulus, a more effective and safer agent than dipyridamole,
nor is its reproducibility in obtaining such flow reserve
measurements known. Thus, we undertook this study to
establish 1) the agreement between this noninvasive method
(baseline-adenosine contrast-enhanced transthoracic Dopp-
ler) with IDFW in assessing CFR in the LAD, and 2) the
reproducibility of CFR measurements as assessed by this
new method.
METHODS
Study group. Twenty-five patients (21 men; ages 44 to 79;
mean age 60 6 8 years) undergoing cardiac catheterization
and intravascular Doppler flow wire in the LAD were
prospectively studied. The patients were submitted to
IDFW for diagnostic purposes. The enrollment was carried
out in a consecutive way on the basis of the catheterization
laboratory decision of performing the IDFW study. This
implied that even patients with large body habitus were
included. All patients underwent coronary angiography
because of suspected or known CAD. Ten patients had
experienced a previous myocardial infarction. All coronary
active medications were withdrawn the morning of the
echocardiographic study. All transthoracic Doppler studies
were performed within 24 h from the intracoronary Doppler
study. Seventeen of the 25 patients had a stenosis affecting
either the proximal, mid- or the distal portion of the LAD.
Eight out of 17 patients with LAD stenosis underwent
coronary angioplasty, and IDFW was performed before and
after angioplasty in five and only after angioplasty in three
patients. All patients were informed of the purpose and
nature of the study, and they provided informed consent.
Transthoracic echocardiography and color Doppler.
Echocardiography was performed with a prototype release
of the Acuson Sequoia ultrasound unit (C256 Echocardi-
ography System, Acuson, Mountain View, California) using
a broadband transducer with second harmonic capability
(3V2c). Its broad bandwidth allows transmission and recep-
tion of ultrasound frequencies over a wide range (from 2 to
3.5 MHz) of values both for B-mode and Doppler modality.
During contrast administration only color Doppler was
performed in second harmonic mode, whereas pulsed-wave
(PW) Doppler was still obtained in fundamental. The
B-mode was obtained in second harmonic mode (1.7 MHz
transmitting frequency and 3.4 MHz receiving) throughout
the study to improve image quality.
A systematic attempt was performed to record flow in the
distal LAD (Fig. 1) in order to have maximal changes to
measure flow velocity distally to a possible stenosis (24
patients). If blood flow was not clearly detectable in the
distal portion, the midpart of the LAD was approached (1
patient). Color Doppler detection of LAD flow was ob-
tained as recently described (6).
Spectral Doppler. To measure coronary flow velocity,
color-coded flow imaging was attained, and then PW
Doppler recording was attempted using color flow as a
guide. If the angle between color flow and Doppler beam was
higher than 20° (two patients), angle correction was performed
using the software package included in the ultrasound unit.
Sample volume positioning was performed taking the diastolic
position of the vessel into account (3). Spectral trace of
coronary flow velocity was characterized by a biphasic flow
with a prevalent diastolic component (Fig. 2). If a relatively
high (.50 cm/s) baseline velocity was recorded, likely indi-
cating acceleration at the stenosis site, a second Doppler
recording (reference value) was performed in a different
arterial segment. The first baseline velocity was discarded
if it was 50% higher than the reference value (7).
Echo contrast enhancement. The Doppler signal en-
hancer used in this study was Levovist (Schering AG,
Berlin, Germany) (7), a suspension of monosaccharide
(galactose) microparticles in sterile water. The echo contrast
agent was administered by infusion using a devoted infusion
pump (IVAC P4000 Anaesthesia Syringe pump, Hamp-
shire, United Kingdom) connected over a special 50-cm
connector tubing (Medrad, Medrad, Indianola, Pennsylva-
nia) to an indwelling cannula (20 to 22 gauge), which was
inserted into a cubital vein.
Intensity of enhancement is related to two contrast
parameters: concentration and infusion rate. On the basis of
previous experience, we used a concentration of 300 mg/ml
(7,8). Regarding infusion rate, we started with 1 mg/min of
a volume of 6 to 7 ml. This rate, during the same infusion,
was increased to a maximum of 2 ml/min or decreased to a
Abbreviations and Acronyms
CAD 5 coronary artery disease
CFR 5 coronary flow reserve
IDFW 5 intracoronary Doppler flow wire
LAD 5 left anterior descending coronary artery
PTCA 5 percutaneous transluminal coronary
angioplasty
PW 5 pulsed wave
TEE 5 transesophageal echocardiography
TTE 5 transthoracic echocardiography
1194 Caiati et al. JACC Vol. 34, No. 4, 1999
Assessing Coronary Flow Reserve October 1999:1193–200
minimum of 0.5 ml/min according to the quality and entity
of the Doppler signal enhancement achieved. Contrast
administration was performed both at baseline and during
drug induced hyperemia.
Transthoracic CFR study protocol. Each patient under-
went a color-guided PW Doppler recording of coronary
blood velocity in the LAD in baseline condition and after
pharmacologic hyperemic stimulus: in 23 studies IV aden-
osine (0.14 mg/kg per minute for 5 min) was used as a
hyperemic agent, whereas in the other 7 studies, IV dipyr-
idamole (0.54 mg/kg over 4 min followed by 4 min of no
dose and then 0.28 mg/kg over 2 min). When adenosine
was used, ultrasound contrast was administered simulta-
neously. Thus, two separate IV lines were used. The
baseline part of the adenosine study was obtained in the first
minute of Doppler enhancement before commencing simul-
taneous adenosine infusion.
In contrast, when dipyridamole was used, two separate
infusions of the echo contrast agent were given: one for the
baseline and the other for the dipyridamole part of the
study. No simultaneous administrations of contrast and
dipyridamole were performed. The second contrast infusion
was started a few seconds after terminating dipyridamole
administration protocol. Coronary flow evaluation was per-
formed using fundamental color Doppler before contrast
infusion and using second harmonic color Doppler during
contrast infusion.
Echocardiographic measurements. The CFR assessment
was performed by one experienced echocardiographer
Figure 1. Color Doppler flow mapping in the distal LAD before
(A, upper panel) and after contrast enhancement (A, lower
panel). A modified 2-chamber view has been obtained: Artist’s
rendering of this tomographic plane orientation to LAD is
illustrated in (B). Before enhancement (A, upper panel) LAD
flow is barely detected (score 2) by color Doppler in fundamental
mode in the anterior groove area (epicardial side of the left
ventricular anterior wall marked by arrows). After enhancement
(contrast infusion in combination with color Doppler in second
harmonic mode) (A, lower panel) color-coded blood flow in the
LAD is clearly depicted (indicated by arrows). LAD 5 left
anterior descending coronary artery; LV 5 left ventricle.
Figure 2. Spectral Doppler tracing by sampling in the distal LAD
before (upper left panel) and after contrast enhancement (upper
mid-panel) at rest. Before contrast infusion, spectral Doppler
signal is scarcely detectable (score 2). After contrast enhancement,
a biphasic flow with a prevalent diastolic component is clearly
depicted (score 3). Abbreviations as in Figure 1.
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blinded to the clinical and angiographic data. Measure-
ments were made off-line, using the built-in calculation
package of the Acuson Sequoia ultrasound unit. The fol-
lowing coronary flow velocity parameters were measured
before and during hyperemia: peak and mean diastolic
velocity peak and mean systolic velocity. For each parameter
the highest 3 (in case of sinus rhythm: 29 cases) or 6 cycles
(in case of atrial fibrillation: 1 case) were averaged. The
CFR was calculated as the ratio of hyperemic to basal peak
(peak CFR) and mean (mean CFR) diastolic flow velocity.
Reproducibility of CFR measurements was assessed by
repeating CFR evaluation twice, 1 h apart, by the same
operator in a subgroup of 13 patients. The reproducibility
study was carried out only with adenosine, and the second
CFR was assessed only if the first evaluation had not
induced ischemia or side effects in the patient.
Coronary angiography. An experienced independent ob-
server who was unaware of patients’ clinical status or
echocardiographic Doppler results visually read all coronary
angiograms. Stenosis severity was expressed, as usual, in
terms of percent diameter narrowing. Calipers were used in
case of questionable findings.
Doppler flow wire. Intravascular velocity measurement in
the LAD was attained by means of a 0.014-in., 14-MHz
Doppler guide wire (FloWire, Cardiometrics, Inc.) at rest
and after hyperemic stimulus. In all patients but one,
intracoronary Doppler velocity measurement was performed
after transthoracic harmonic Doppler study. The intracoro-
nary Doppler guide wire was advanced through the guiding
catheter to a position 2 to 3 cm distal to the stenotic lesion
if present. Otherwise, it was placed in a proximal LAD site.
Care was taken to avoid placement in a side branch or
post-stenotic velocity jet. Spectral Doppler signal was then
recorded at baseline and after 18-mg intracoronary bolus of
adenosine (9). Hyperemic stimulus was repeated at least
twice. Curves without optimal delineation of both systolic
and diastolic waves were discarded. Doppler flow velocity
spectra were automatically analyzed online to determine
time-averaged peak velocity. Coronary flow reserve was then
computed as the ratio of hyperemic to basal average peak
velocity. If repeated CFR measurements in the same pa-
tients gave discordant results, an average CFR value was
considered.
Statistical analysis. Continuous data are expressed as mean
and standard deviation (SD). Two-way repeated-measures
ANOVA (analysis of variance) (Statistica, Version 5, 1997,
Statsoft, Inc.) with two repeated-measures factors (i.e., drug
intervention [no drug vs. drug] and type of Doppler exam-
ination [transthoracic vs. intracoronary Doppler]) was used
to test for the effects and interactions of the different levels
of these two factors on the hemodynamic variables (namely
heart rate and systolic and diastolic blood pressure). The
Newman-Keuls test was used for post hoc analysis.
Correlation between CFRs measured by the two methods
and by the same method was evaluated using both a linear
regression analysis expressed as the correlation of coefficient
(r) and the Bland-Altman method for assessing the limits of
agreement between the repeated measurements (10).
RESULTS
Doppler curves suitable for the analysis were obtained in all
patients (CFR feasibility: 100%). In five patients CFR
measurements were performed twice (before and after per-
cutaneous transluminal coronary angioplasty [PTCA]) by
both methods. Overall, 30 CFR measurements were com-
pared.
Hemodynamic data. No major adverse reactions occurred
during hyperemia. Heart rate was higher during the trans-
thoracic Doppler compared with the intracoronary Doppler
study owing to the adenosine effect (F for interaction 5 52;
p , 0.01) (Table 1). Systolic blood pressure was not
different between the two Doppler methods, nor did aden-
osine have a significant effect (Table 1). Diastolic blood
pressure was constantly and significantly lower during the
intracoronary as compared with the transthoracic study (p ,
0.01), and adenosine did not cause any significant change to
this variable (Table 1).
Transthoracic versus intravascular CFR. Coronary flow
reserve as assessed by this new method closely agreed with
IDFW CFR (Figs. 3 and 4). In all but five patients, in fact,
the difference between intracoronary and transthoracic CFR
was a maximum of 0.38 (Fig. 5; Table 2). Overall, the
prediction interval (95%) of individual differences was 0.72
(95% confidence interval [CI], 0.43 to 1.03) and 20.69
(95% CI, 20.99 to 20.39). Considering CFR as a categor-
ical variable (normal or abnormal on the basis of a largely
Table 1. Hemodynamic Findings
Transthoracic Study Intracoronary Study
Baseline Hyperemia Baseline Hyperemia
Heart rate (beats/min) 65 6 9 80 6 12* 67 6 12 68 6 13
Systolic BP (mm Hg) 122 6 20 123 6 24 121 6 24 120 6 23
Diastolic BP (mm Hg) 77 6 15 78 6 14 66 6 11† 61 6 11†
*p , 0.001 versus baseline transthoracic. †p , 0.001 versus transthoracic study.
BP 5 blood pressure.
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accepted cutoff value of 2) (11), the agreement between the
two methods was 97%. In the patient with the largest CFR
measurement disagreement (Patient 1 in Table 2), coronary
angiography revealed a “very distal” mid-LAD stenosis and
a long diagonal branch stemming off the LAD proximally to
the stenosis and leading to the apex.
CFR measurement reproducibility. Reproducibility of
CFR measurement was high (r 5 0.97) (Fig. 6). The
difference between the two measurements was a maximum
0.25 in all but one patient. As a whole, the mean difference
was zero (no bias was found) and the upper and lower limits
of agreement between the two approaches were, respec-
tively, 10.32 (95% CI, 10.16 to 10.48) and 20.32 (95%
CI, 20.48 to 20.16).
DISCUSSION
This study demonstrates that transthoracic harmonic color
Doppler and PW Doppler in conjunction with IV injection
of an echo contrast agent with appropriate ultrasound
characteristics (4) offers feasible, reliable and reproducible
evaluation of blood flow velocity in the LAD at rest and
during hyperemia, allowing accurate CFR determination in
the LAD in a completely noninvasive way.
The CFR measurements are strictly in agreement with
CFR as assessed by IDFW (limits of agreement: 20.69 to
10.72), a highly reliable and reproducible method in
assessing CFR (9,12) (Fig. 5). The reproducibility of mea-
surements of CFR was high (r 5 0.97) (Fig. 6).
Echo-Doppler enhancement: Methodologic consider-
ations. The high success rate in detecting coronary flow in
the LAD relies on the combination of contrast enhance-
ment with second harmonic technology. Contrast enhance-
ment has proved to be useful in increasing Doppler signal-
to-noise ratio in coronaries by increasing the amplitude of
the signal (7,8). In addition, harmonic Doppler imaging
with echo contrast agents capable of nonlinear emission of
harmonics can further increase the signal-to-noise ratio by
eliminating flashing and clutter artifacts coming from the
tissue without significantly reducing the signal from blood
(4,5).
Color Doppler recording of coronary blood flow is of
crucial methodologic importance in measuring flow in that
it allows optimal color-coded flow detection in the LAD
and, thereby, more appropriate PW sample volume posi-
tioning (Figs. 1 and 2). We administered contrast by
infusion and not by bolus. This administration modality of
the echo contrast agent has the advantage of maintaining
over several minutes (depending on the total injected
volume) the enhancing effect of the agent.
Correlation with Doppler flow wire. The high agreement
between intracoronary and transthoracic Doppler measure-
ments relies on the high quality of spectral tracing obtained
by enhanced TTE Doppler, and more important, because
Doppler sampling by TTE Doppler was very likely per-
formed in the post-stenotic segments as was Doppler flow
wire. In fact, sampling by TTE Doppler was performed in
all patients in the distal LAD segment. This makes it almost
certain to be positioned in a post-stenotic segment in
patients with proximal and mid-LAD stenosis. Post-
stenotic CFR is much more accurate than prestenotic CFR
in assessing residual vasodilatory capacity of the vascular bed
subtended to a narrowed coronary artery (13). In fact, CFR
measured in regions with branches proximal to the lesion is
pseudo-normalized and, thus, is diagnostically unreliable
because flow is concurrently assessed for regions of varying
vasodilatory reserve, hence reflecting a weighted average of
these potentially disparate zones. In a recent study (14)
aimed at comparing CFR evaluated by TEE Doppler (a
Figure 4. Example of a patient with an abnormal CFR. Enhanced
transthoracic (top) and intracoronary Doppler (bottom) are
shown. A blunted response is depicted by both methods. Angiog-
raphy showed a subocclusive proximal LAD stenosis. Abbrevia-
tions as in Figures 1 and 3.
Figure 3. Example of a patient with a normal CFR. Enhanced
transthoracic spectral tracing is shown at the top (at the baseline,
left upper panel, and during hyperemia, right upper panel). The
corresponding velocity curves obtained by IDFW are shown at the
bottom. Velocities and CFRs are almost identical by the two
methods. The shapes of the curves are also similar. CFR 5
coronary flow reserve; IDFW 5 intracoronary Doppler flow wire.
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technique that by definition is able to assess only prestenotic
CFR because velocity recording is made in the proximal
LAD) with CFR measurements obtained with intracoro-
nary Doppler flow wire in the post-stenotic segment, no
correlation (r 5 0.181) was found between the two meth-
ods.
In cases 1, 8, 10 bis and 15 bis (Table 2) transthoracic
Doppler considerably underestimated or overestimated
IDFW results. Case 1 overestimation by TTE Doppler is
very likely explainable because CFR was probably assessed
in a normal diagonal branch (stemming off the LAD before
the 60% stenosis) instead of that in the distal LAD. This
could rarely happen in patients with big diagonal branches
leading to the left ventricular apex. Alternatively, but less
likely, we could have sampled proximally to the stenosis. In
case 8 bis the difference can be explained by different effects
of dipyridamole on coronary microcirculation with respect
to intracoronary adenosine. Dipyridamole, in fact, produces
maximal hyperemia in a smaller percentage of patients than
does intracoronary adenosine, assuming a papaverine effect
as the reference maximal effect (9). In Patients 10 bis and 15
bis the overestimation of CFR by TTE Doppler can
probably be justified by the fact that a certain recovery of
CFR at the time of the transthoracic study (performed 24 h
after revascularization and IDFW evaluation) might have
taken place (15).
CFR measurement reproducibility. Short-term reproduc-
ibility of CFR measurement by enhanced transthoracic
Doppler was very high (limits of agreement: 20.3 to 10.3)
paralleling the reproducibility of IDFW (9). That this new
method is reproducible is also supported by the agreement
with a very reproducible method such as IDFW. In addition
to the precision of the measurements, the noninvasiveness
of this approach aids in keeping measurements repeatable.
Thanks to its total noninvasiveness, in fact, our method
does not alter per se hemodynamics (in particular, heart
rate), thus not introducing an important source of variability
of CFR measurements as previous studies have clearly
demonstrated (16).
Transthoracic echo Doppler assessment of coronary flow
and reserve. This study confirms and expands our prelim-
inary data comparing CFR as assessed by this new method
with a gold-standard method such as IDFW. In that
previous experience, a small series of patients (16) was
studied; furthermore, in accordance with our previous pro-
tocol, dipyridamole was used instead of adenosine. Adeno-
sine, however, is a more powerful vasodilator that best suits
our echo contrast administration protocol requirements
thanks to its rapid action and favorable kinetics (17). Thus,
in this last series a new approach with adenosine was
adopted in all patients except the first seven enrolled, in
which the old protocol using dipyridamole was still used.
Transthoracic ultrasound without enhancement has been
attempted in the past to visualize distal LAD and in some
studies also to record Doppler flow (18,19). However, the
success rate in visualizing the artery and to record the flow
was so low that CFR evaluation was not attempted. It is
interesting to note that our precontrast feasibility data (6)
parallel those of these reports.
Study limitations. Some methodologic or hemodynamic
factors could have partially affected comparison of the
methods: 1) transthoracic and intracoronary Doppler eval-
uations were not performed simultaneously for logistical
reasons; 2) adenosine was administered via different routes
(IV vs. intracoronary) and in seven patients dipyridamole
was used during TTE Doppler evaluation instead of IV
adenosine. Although it has been proved that both dipyrid-
amole and IV adenosine provide almost the same effect in
terms of coronary microcirculation dilation (20), this can
account for individual discrepancies; 3) during IDFW study,
diastolic blood pressure was slightly but significantly lower
than during transthoracic Doppler study. Also, the heart
rate significantly increased after IV adenosine, and it re-
mained unchanged after intracoronary bolus (Table 1).
However, these minor changes in hemodynamic conditions
probably did not affect CFR, as previously demonstrated
(16).
Some potential limitations of this new method need to be
Figure 5. Scattergram (left panel) showing the relation between CFR obtained by two methods: enhanced transthoracic Doppler (x-axis)
and IDFW (y-axis). Lines of equality (dotted line) and correlation (continuous line) are shown. Plot of the difference (right panel)
between the CFR obtained by the two above-mentioned methods against their mean. Dotted lines represent boundaries of mean 6 2 SD.
E-TTE 5 enhanced transthoracic Doppler; IDFW 5 intracoronary Doppler flow wire; Diff 5 difference. Other abbreviations as in Figure 3.
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discussed. First, blood flow velocity in a big diagonal branch
leading to the apex could be erroneously considered as blood
flow velocity in the distal LAD (Patient 1 in Table 2).
Second, in CAD patients with distal lumen narrowing,
prestenotic CFR can be assessed despite an attempt to
measure flow velocity in the distal LAD. Third, CFR
assessment can be invalidated if the noninvasive CFR
measurement is performed at the stenosis site. In our study,
Figure 6. Scattergram (left panel) showing the relation between CFRs obtained by the same method (transthoracic Doppler) 1 h apart.
Lines of equality (dotted line) and correlation (continuous line) are shown. Plot of the difference (right panel) between the two CFR
measurements against their mean is shown. Dotted lines represent boundaries of mean 6 2 SD. Abbreviations as in Figure 3.








1 Aden MI 60%; mid 3.46 2.22
2 Aden MI 0% 3.60 3.55
3 Aden Angina; Post-PTCA 40%; prox 2.79 2.86
4 Aden Angina 50%; mid 2.06 2.41
5 Aden MI 0% 3.24 3.29
6 Dip Angina 70%; distal 2.07 2.24
7 Aden MI 0% 1.91 2.29
8 Dip MI 40%; distal 3.64 4.25
9 Dip MI (pre-PTCA) 85%; mid 1.33 1.67
9 bis Dip Post-PTCA , 20%; mid 3.05 3.54
10 Aden Angina (pre-PTCA) 70%; mid–60%; distal 2.02 2.09
10 bis Aden Post-PTCA 0% 1.83 1.28
11 Aden MI 0% 2.48 2.57
12 Dip Angina 40%; distal 4.35 4.42
13 Aden MI 50%; mid 2.71 2.47
14 Aden Angina 50%; mid 2.89 2.90
15 Dip MI (pre-PTCA) 90%; mid 1.33 1.56
15 bis Dip Post-PTCA 20%; mid 3.26 2.80
16 Aden Angina; LVH 0% 1.37 1.70
17 Aden MI (pre-PTCA) 75%; prox 295%; mid 1.06 1.17
17 bis Aden Post-PTCA 30%; prox 20%; mid 2.06 2.29
18 Aden Angina; MR 0% 1.72 1.58
19 Aden MI 95%; mid 1.24 1.17
20 Aden Angina 80%; distal 1.62 1.57
21 Aden Angina 0% 3.03 3.11
22 Aden Angina (post-PTCA) 60%; distal 1.62 1.55
23 Aden Angina 60%; prox 2.28 2.18
24 Aden MI (post-PTCA) 70%; distal 1.66 1.46
25 Aden Angina (pre-PTCA) 90%; prox 1.47 1.78
25 bis Aden Post-PTCA 0% 3.26 3.00
Mean 6 SD — — — 2.35 6 0.87 2.36 6 0.87
TTE drug 5 drug used to induce hyperemia during transthoracic Doppler study; Aden 5 IV adenosine; Dip 5 dipyridamole; E-TTE 5 enhanced transthoracic Doppler;
IDFW 5 intracoronary Doppler flow wire; prox 5 proximal LAD segment; mid 5 mid-LAD segment; distal 5 distal LAD segment; LVH 5 severe left ventricular hypertrophy;
MI 5 myocardial infarction; MR 5 severe mitral regurgitation; PTCA 5 percutaneous transluminal coronary angioplasty.
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to circumvent this problem in patients with relatively high
baseline velocity (.50 cm/s), possibly indicating accelera-
tion at the stenosis site, a second Doppler sampling (refer-
ence value) was obtained in a different portion of the artery
(7). Fourth, in a certain number of cases the theta angle was
quite large (.30°), causing an underestimation of the true
velocity. However, for the purpose of the CFR evaluation
the absolute velocity value was not needed because CFR is
a quotient of two velocities. Fifth, we measured a CFR
index using a simple ratio of two velocities. This, however,
as previously pointed out by others (21), is a reliable
indicator of CFR.
Clinical implication. This completely noninvasive method
to assess CFR has potentially interesting clinical applica-
tions. It may provide additional information to cardiac
catheterization in the assessment of LAD coronary stenosis,
especially those of intermediate anatomic severity whose
functional influence, as indicated by previous observations
(13), can be precisely assessed only with the post-stenotic
CFR evaluation. It may also be useful in the assessment of
the effect of PTCA procedure on the LAD either for early
detection of restenosis or for monitoring CFR recovery
modalities (15) (see Patients 10 bis and 17 bis in Table 2);
in the noninvasive detection of LAD stenosis in situations
such as in left bundle branch block, stress tests (both
scintigraphy and echocardiography) are not reliable because
of the high number of false positive studies; in assessing
microcirculation impairment in conditions affecting CFR in
the absence of CAD (see Patients 16 and 18 in Table 2);
and because of the possible serial evaluation for exploring
short- and long-term effects of various therapeutic interven-
tions on CFR.
In conclusion, enhanced TTE Doppler closely agrees
with IDFW in assessing CFR in the LAD. This new
noninvasive method is feasible, reliable and reproducible in
evaluating CFR in the LAD. Because of its noninvasive
nature, this new method has a potential both in patho-
physiologic and clinical studies. Larger studies are needed to
investigate its potential in various diseases with possible
CFR impairment.
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